Molecules 2021, 26, 1330
10 of 14
δ: 7.96 (d, J = 8.7 Hz, 2H), 7.15–6.78 (m, 4H), 6.68 (d, J = 8.0 Hz, 1H), 6.56 (s, 1H), 5.06
(
d, J = 11.7 Hz, 1H), 4.71 (bs, 1H), 3.89 (s, 3H), 2.75 (s, 6H), 2.23 (s, 3H), 2.07 (dd, J = 13.0,
2.8 Hz, 1H), 1.74 (t, J = 12.8 Hz, 1H), 1.64 (s, 3H) ppm. 13C-NMR (63 MHz, CDCl3)
: 197.9,
163.9, 143.6, 140.4, 130.7, 128.4, 127.6, 126.9, 126.8, 116.0, 114.1, 55.6, 53.8, 43.4, 40.9, 39.3,
26.3, 20.6 ppm. IR (neat)
: 3356.2, 2961.2, 1668.2, 1601.3 cm-1. Elemental analysis (%): Calc.
δ
ν
for C22H27N3O2 (M = 365.48): C, 72.30; H, 7.45; N, 11.50. Found: C, 72.17; H, 7.31; N, 11.27.
mp: 118-121 ◦C.
3.2.12. (±)-(2. R,4R)-4-((2,2-Dimethylhydrazineylidene)methyl)-2-(4-
methoxybenzoyl)-4,6,8-trimethyl-1,2,3,4-tetrahydroquinoline (2l)
Prepared from the in situ-generated imine 1j (0.5 mmol) and (E)-1,1-dimethyl-2-(2-
methylallylidene)hydra- zine (84 mg, 0.75 mmol). Chromatography: petroleum ether:
1
ethyl acetate 95:5. Yield: 188 mg (99 %), as a yellow solid. H NMR (250 MHz, CDCl3)
δ:
8.05–7.91 (m, 2H), 7.01–6.95 (m, 2H), 6.83 (s, 1H), 6.76 (s, 1H), 6.57 (s, 1H), 5.10 (dd, J = 12.5,
2.8 Hz, 1H), 4.55 (bs, 1H), 3.90 (s, 3H), 2.74 (s, 6H), 2.21 (s, 6H), 2.07 (dd, J = 13.0, 2.8 Hz,
1H), 1.70 (t, J = 12.7 Hz, 1H), 1.66 (s, 3H) ppm. 13C NMR (63 MHz, CDCl3)
δ
: 198.0, 163.9,
144.2, 138.4, 130.8, 129.7, 127.6, 126.4, 126.3, 126.2, 123.5, 114.2, 55.7, 53.9, 43.5, 41.0, 39.3,
26.2, 20.6, 17.6 ppm. IR (neat)
: 3365.9, 2954.7, 1669.2, 1611.2 cm−1. Elemental analysis (%):
ν
Calc. for C23H29N3O2 (M = 379.50): C, 72.79; H, 7.70; N, 11.07. Found: C, 72.51; H, 7.34; N,
11.36. mp: 137–140 ◦C.
3.2.13. (±)-(2. R,4R)-4-((2,2-Dimethylhydrazono)methyl)-2-(4-fluorobenzoyl)-6-
methoxy-4-methyl-1,2,3,4-tetrahydroquinoline (2m)
Prepared from the in situ-generated imine 1k (0.5 mmol) and (E)-1,1-dimethyl-2-(2-
methylallylidene)hydra- zine (84 mg, 0.75 mmol). Chromatography: petroleum ether: ethyl
acetate 92:8. Yield: 172 mg (93%), as a yellow solid. Characterization data were identical to
those described in the literature. [13]
3.2.14. (±)-(2. R,4R)-4-((2,2-Dimethylhydrazono)methyl)-4-ethyl-2-
(4-fluorobenzoyl)6,8-dimethyl-1,2,3,4-tetrahydroquinoline (2n)
Prepared from the in situ-generated imine 1l (0.5 mmol) and (E)-1,1-dimethyl-2-(2-
methylenebutylidene)hy- drazine (95 mg, 0.75 mmol). Chromatography: petroleum ether:
1
ethyl acetate 95:5. Yield: 189 mg (99%), as a viscous yellow liquid. H-NMR (250 MHz,
CDCl3)
J = 11.4 Hz, 1H), 4.53 (bs, 1H), 2.71 (s, 6H), 2.22–2.17 (m, 7H), 2.05 (q, J = 7.3 Hz, 2H), 1.68 (t,
J = 12.9 Hz, 1H), 1.01 (t, J = 7.3 Hz, 3H) ppm. 13C-NMR (63 MHz, CDCl3)
: 198.8, 166.0 (d,
J = 252 Hz), 142.0, 138.2, 131.4 (d, J = 2.9 Hz), 131.0 (d, J = 9 Hz), 129.7, 126.6, 125.9, 125.5,
δ: 8.12–7.85 (m, 2H), 7.24–7.10 (m, 2H), 6.83 (s, 1H), 6.74 (s, 1H), 6.55 (s, 1H), 5.07 (d,
δ
123.1, 116.2 (d, J = 25.2 Hz), 54.1, 43.7, 43.4, 35.2, 30.7, 20.7, 17.8, 9.3 ppm. IR (neat) ν: 3370.9,
2964.5, 1673.1, 1603.3 cm−1. Elemental analysis (%): Calc. for C23H28FN3O (M = 381.50): C,
72.41; H, 7.40; N, 11.01. Found: C, 72.10; H, 7.10; N, 10.57.
3.2.15. (±)-(2. R,4R)-4-((2,2-Dimethylhydrazono)methyl)-6-methoxy-4-methyl-2-
(4-methylbenzoyl)-1,2,3,4-tetrahydro-1,5-naphthyridine (2o)
Prepared from the in situ-generated imine 1m (0.5 mmol) and (E)-1,1-dimethyl-2-
(2-methylallylidene)hydrazine (84 mg, 0.75 mmol). Chromatography: petroleum ether:
1
ethyl acetate 8:1. Yield: 156 mg (85%), as a yellow solid. H-NMR (300 MHz, CDCl3)
δ:
7.90 (d, J = 8.3 Hz, 2H), 7.33 (d, J = 7.9 Hz, 2H), 7.20 (bs, 1H), 7.07 (d, J = 8.6 Hz, 1H), 6.53
d, J = 8.6 Hz, 1H), 5.04 (dd, J = 12.2, 2.8 Hz, 1H), 3.86 (s, 3H), 2.70 (s, 6H), 2.46 (s, 3H), 2.28
(dd, J = 13.5, 2.8 Hz, 1H), 2.09–1.94 (m, 1H), 1.68 (s, 3H) ppm. 13C-NMR (75 MHz, CDCl3)
: 199.5, 157.2, 145.0, 144.7, 143.5, 132.9, 132.5, 130.0, 129.0, 128.7, 109.5, 54.6, 53.6, 43.7, 42.2,
38.1, 27.2, 22.1 ppm. IR (neat)
: 3316.1, 2960.5, 1676.8, 1605.5 cm−1. Elemental analysis (%):
(
δ
ν
Calc. for C21H26N4O2 (M = 366.46): C, 68.83; H, 7.15; N, 15.29. Found: C, 68.62; H, 6.80; N,
14.90. mp: 123–125 ◦C.